Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Guardant Health (Nasdaq: GH), a leading precision oncology company, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's management team will deliver a presentation followed by a Q&A session on Monday, January 13, at 4:30 p.m. Pacific Time / 7:30 p.m. Eastern Time.
Interested investors and stakeholders can access both live and archived webcasts of the sessions through the 'Investors' section of Guardant Health's official website at www.guardanthealth.com.
Guardant Health (Nasdaq: GH), un'azienda leader nella oncologia di precisione, ha annunciato la sua partecipazione al 43° Congresso Annuale J.P. Morgan Healthcare a San Francisco. Il team di gestione dell'azienda presenterà un intervento seguito da una sessione di domande e risposte lunedì 13 gennaio alle 16:30 ora del Pacifico / 19:30 ora dell'Est.
Investitori e parti interessate possono accedere sia alle dirette che alle registrazioni archiviate delle sessioni attraverso la sezione 'Investitori' del sito ufficiale di Guardant Health all'indirizzo www.guardanthealth.com.
Guardant Health (Nasdaq: GH), una empresa líder en oncología de precisión, ha anunciado su participación en la 43ª Conferencia Anual de Salud J.P. Morgan en San Francisco. El equipo de gestión de la empresa realizará una presentación seguida de una sesión de preguntas y respuestas el lunes 13 de enero a las 4:30 p.m. hora del Pacífico / 7:30 p.m. hora del Este.
Los inversores y partes interesadas pueden acceder tanto a las transmisiones en vivo como a las grabaciones archivadas de las sesiones a través de la sección 'Inversores' en el sitio web oficial de Guardant Health en www.guardanthealth.com.
가드란트 헬스 (Nasdaq: GH)는 정밀 종양학 분야의 선두 기업으로서 샌프란시스코에서 열리는 제43회 연례 J.P. 모건 헬스케어 컨퍼런스에 참가한다고 발표했습니다. 회사의 경영진은 1월 13일 월요일 오후 4시 30분(태평양 표준시) / 오후 7시 30분(동부 표준시)에 발표를 진행한 후 질의응답 세션을 진행할 예정입니다.
관심 있는 투자자와 이해관계자는 가드란트 헬스의 공식 웹사이트 www.guardanthealth.com의 '투자자' 섹션을 통해 세션의 생방송과 저장된 웹캐스트에 접근할 수 있습니다.
Guardant Health (Nasdaq: GH), une entreprise leader en oncologie de précision, a annoncé sa participation à la 43ème Conférence Annuelle J.P. Morgan Healthcare à San Francisco. L'équipe de direction de l'entreprise présentera une intervention suivie d'une session de questions-réponses le lundi 13 janvier à 16h30 heure du Pacifique / 19h30 heure de l'Est.
Les investisseurs et parties prenantes intéressés peuvent accéder aux webcasts en direct ainsi qu'aux enregistrements archivés des sessions via la section 'Investisseurs' du site officiel de Guardant Health à l'adresse www.guardanthealth.com.
Guardant Health (Nasdaq: GH), ein führendes Unternehmen im Bereich präzise Onkologie, hat seine Teilnahme an der 43. Jahreskonferenz von J.P. Morgan Healthcare in San Francisco angekündigt. Das Managementteam des Unternehmens wird am Montag, den 13. Januar, um 16:30 Uhr pazifischer Zeit / 19:30 Uhr östlicher Zeit eine Präsentation halten, gefolgt von einer Frage-und-Antwort-Runde.
Interessierte Investoren und Interessensvertreter können sowohl Live- als auch archivierte Webcasts der Sitzungen über den Bereich 'Investoren' der offiziellen Website von Guardant Health unter www.guardanthealth.com abrufen.
- None.
- None.
Guardant Health’s management is scheduled to present and participate in a Q&A session on Monday, January 13, at 4:30 p.m. Pacific Time / 7:30 p.m. Eastern Time. Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com.
About Guardant Health
Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.
Source: Guardant Health, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250102745653/en/
Investor Contact:
Zarak Khurshid
investors@guardanthealth.com
Media Contact:
Michael Weist
press@guardanthealth.com
+1 317-371-0035
Source: Guardant Health, Inc.
FAQ
When is Guardant Health (GH) presenting at the J.P. Morgan Healthcare Conference?
How can investors watch Guardant Health's (GH) J.P. Morgan Conference presentation?
What type of session will Guardant Health (GH) conduct at the J.P. Morgan Healthcare Conference?
Which healthcare conference is Guardant Health (GH) participating in?
